A free lecture course “The Science of Small Clinical Trials” is now open for registration. The survey course covers methods to design and analyze clinical trials using small numbers of participants and is provided by The National Institutes of Health Office of Rare Diseases Research in conjunction with the Food and Drug Administration Office of Orphan Products Development. This topic of how to design conduct and interpret smal lclinical trials is highly relevant to neurofibromatosis where small clinical trials – such as those funded by the Children’s Tumor Foundation Clinical Trials Award – are likely to play an important part in advancing neurofibromatosis drug therapies.
The course comprises 7 x 2-hour lectures in February and March, and can be attended in person (NIH campus in Bethesda, MD) or online. Remote attendees will be able to submit questions to the speaker. An optional self-administered open-book on-line examination concludes the course to qualify for a certificate from FDA’s Office of Orphan Products Development. More information and registration: http://small-trials.keenminds.org/
